It’s a product launch festival at Mitek Sports Medicine, which has just announced the launch of two new products: MONOVISC High Molecular Weight Hyaluronan, a single-injection treatment for knee pain related to osteoarthritis (OA), and the PEAK Platelet Rich Plasma (PRP) System, a device that produces PRP in only 2.5 minutes.
Mitek Launches OA Injection and PRP System
2 min read Premium comments
Secondary
“Both products are important new early intervention options for sports medicine physicians and their patients, ” said Peter Vitanzo, M.D., sports medicine specialist at the Rothman Institute in Philadelphia, in the July 11, 2014 news release. “These products give us more non-operative tools to personalize the approach for the individual patient based on their level of activity, degree of injury and treatment preference.”
MONOVISC, meant for patients who have had no luck with conservative treatment, is delivered in a single-injection hyaluronan treatment. Patients with knee OA may experience up to six months of pain relief as well as the restoration of joint mobility. It is injected directly into the knee to help replace the naturally occurring hyaluronan found in healthy joint fluid, and to cushion, protect and lubricate the knee joint.
As indicated by the company, MONOVISC is the only single-injection treatment with hyaluronic acid produced from a non-avian source, thereby reducing the risk for allergic reaction in some patients. Mitek Sports Medicine is the exclusive marketer and distributor of MONOVISC and ORTHOVISCHigh Molecular Weight Hyaluronan, a multi-injection hyaluronan treatment also used to treat knee pain due to osteoarthritis.
As noted in the news release, Mitek Sports Medicine is the exclusive marketer and distributorofthe PEAK PRP System, which works by separating PRP from a sample of a patient’s own blood. The device consistently produces 3mL of high quality PRP from 27mL of whole blood in 2.5 minutes, yielding up to seven-times the normal concentration of platelets. The processing time is significantly less than competitor systems that have processing times ranging from 10 to 30 minutes. In addition, the PEAK PRP System weighs only four pounds, making it smaller and more portable.
Ian Lawson, Worldwide President, Mitek Sports Medicine, told OTW, “By expanding our early intervention portfolio we are providing physicians with a range of options to help meet varying clinical needs, and helping get patients back to living an active life.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.